Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1971 2
1977 1
1978 1
1987 2
1988 1
1989 1
1990 1
1991 1
1998 1
2001 1
2003 3
2004 1
2005 1
2006 2
2007 6
2008 10
2009 5
2010 5
2011 13
2012 12
2013 20
2014 22
2015 20
2016 20
2017 21
2018 18
2019 17
2020 22
2021 19
2022 26
2023 16
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

253 results

Results by year

Filters applied: . Clear all
Page 1
The influence of immunodeficiency, disease features, and patient characteristics on survival in plasmablastic lymphoma.
Di Ciaccio PR, Polizzotto MN, Cwynarski K, Gerrie AS, Burton C, Bower M, Kuruvilla J, Montoto S, McKay P, Fox CP, Milliken S, Jiamsakul A, Osborne W, Collins GP, Manos K, Linton KM, Iyengar S, Kassam S, Limei MP, Kliman D, Wong Doo N, Watson AM, Fedele P, Yannakou CK, Hunt S, Ku M, Sehn LH, Smith A, Renshaw H, Maxwell A, Liu Q, Dhairyawan R, Ferguson G, Pickard K, Painter D, Thakrar N, Song KW, Hamad N. Di Ciaccio PR, et al. Among authors: kuruvilla j. Blood. 2024 Jan 11;143(2):152-165. doi: 10.1182/blood.2023021348. Blood. 2024. PMID: 37832030 Free article.
Very late relapse in Hodgkin lymphoma: Characterizing an understudied population.
Cherniawsky H, Ting E, Zhang JZ, Xu W, Prica A, Bhella S, Yang C, Kridel R, Vijenthira A, Kukreti V, Crump M, Kuruvilla J. Cherniawsky H, et al. Among authors: kuruvilla j. Clin Lymphoma Myeloma Leuk. 2023 Nov;23(11):838-843. doi: 10.1016/j.clml.2023.07.012. Epub 2023 Jul 31. Clin Lymphoma Myeloma Leuk. 2023. PMID: 37562990 Review.
Comparative effectiveness of salvage chemotherapy regimens and chimeric antigen T-cell receptor therapies in relapsed and refractory diffuse large B cell lymphoma: a network meta-analysis of clinical trials.
Gong IY, Aminilari M, Landego I, Hueniken K, Zhou Q, Kuruvilla J, Hodgson DC. Gong IY, et al. Among authors: kuruvilla j. Leuk Lymphoma. 2023 Oct;64(10):1643-1654. doi: 10.1080/10428194.2023.2234528. Epub 2023 Aug 7. Leuk Lymphoma. 2023. PMID: 37548344
Nivolumab for relapsed/refractory classical Hodgkin lymphoma: 5-year survival from the pivotal phase 2 CheckMate 205 study.
Ansell SM, Bröckelmann PJ, von Keudell G, Lee HJ, Santoro A, Zinzani PL, Collins GP, Cohen JB, de Boer JP, Kuruvilla J, Savage KJ, Trněný M, Provencio M, Jäger U, Willenbacher W, Wen R, Akyol A, Mikita-Geoffroy J, Shipp MA, Engert A, Armand P. Ansell SM, et al. Among authors: kuruvilla j. Blood Adv. 2023 Oct 24;7(20):6266-6274. doi: 10.1182/bloodadvances.2023010334. Blood Adv. 2023. PMID: 37530622 Free PMC article. Clinical Trial.
The Use of Salvage Chemotherapy for Patients with Relapsed Testicular Germ Cell Tumor (GCT) in Canada: A National Survey.
Al-Ezzi EM, Zahralliyali A, Hansen AR, Hamilton RJ, Crump M, Kuruvilla J, Wood L, Nappi L, Kollmannsberger CK, North SA, Winquist E, Soulières D, Hotte SJ, Jiang DM. Al-Ezzi EM, et al. Among authors: kuruvilla j. Curr Oncol. 2023 Jun 27;30(7):6166-6176. doi: 10.3390/curroncol30070458. Curr Oncol. 2023. PMID: 37504318 Free PMC article.
253 results